Market Overview:
The global stem cell drugs market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The market growth can be attributed to factors such as increasing prevalence of chronic diseases, rising demand for regenerative therapies, and technological advancements in the field of stem cell research. Based on type, the global stem cell drugs market is segmented into cord blood-derived, adipose-derived, bone marrow-derived, and others. Cord blood-derived cells are expected to account for the largest share of the global stem cell drugs market in 2018. This can be attributed to their ability to differentiate into various types of cells and tissues and their potential use in regenerative therapies. Adipose tissue is also a rich source of mesenchymal stromal cells (MSCs), which have been shown to possess therapeutic potential in several diseases. Based on application, the global stem cell drugs market is segmented into acute graft-versus host disease (GVHD), Crohn’s disease, amyotrophic lateral sclerosis (ALS), osteoarthritis (OA), and others. Acute GVHD is a life threatening complication that may occur after hematopoietic stem cell transplantation or umbilical cord blood transplantation.
Product Definition:
A stem cell drug is a medication that is derived from or inspired by stem cells. These drugs can be used to treat a variety of medical conditions, including cancer, heart disease, and diabetes.
Cord Blood-Derived:
Cord blood is the blood that is collected from a baby's umbilical cord and stored in a bank. With the rising number of stem cell research activities, many hospitals and private companies are engaged in collecting and storing this precious liquid for future medical needs.
Stem cells have different capabilities to grow, divide & die; they can also communicate with each other & their surrounding environment by producing & receiving signals.
Adipose-Derived:
Adipose-derived stem cells (ASCs) have been identified as a novel source for the generation of therapeutically relevant cell lines. ASCs are obtained from fat tissues and can be used in the treatment of various diseases such as cardiovascular, neurodegenerative, cancer, and diabetes. The main advantages associated with this source include ease in isolation procedures coupled with high proliferative ability on culture media compared to other sources such as embryonic stem cells (ESCs).
Application Insights:
The acute graft-versus-host disease segment dominated the global market in 2017 and is expected to witness lucrative growth over the forecast period. Acute GVHD affects around 7 out of 100 patients after allogeneic stem cell transplantation, and around 15 out of 100 patients after autologous stem cell transplantation. The treatment for this condition includes steroids and/or antibiotics to reduce inflammation. However, current treatments are not able to prevent chronic GVHD or graft failure, which drives demand for new drugs developed specifically for these conditions.
The Crohn’s disease segment is also expected to grow at a significant rate during the forecast period owing to high unmet medical needs associated with this condition globally as well as locally in countries such as India and China where more than 6 million people are suffering from Inflammatory Bowel Disease (IBD).
Regional Analysis:
North America dominated the global market in 2017. The presence of well-established healthcare facilities, favorable reimbursement policies, and increasing R&D activities are some of the major factors contributing to its growth. In addition, rise in awareness about stem cell therapy is anticipated to fuel regional demand during the forecast period.
Asia Pacific is expected to witness lucrative CAGR over the forecast period owing to rising investments by leading companies for commercialization of their products and improving healthcare infrastructure in emerging countries such as China and India. Furthermore, growing medical tourism industry due to availability of advanced therapies at affordable costs will also boost regional demand during the estimated time span. ‘‘‘‘ ’ â‘‘ ✜œ—'—'—'" -.,.-.'-,.-'.;:;:-.;:'""'-.
Growth Factors:
- Increasing prevalence of chronic diseases: The global stem cell drugs market is expected to grow at a CAGR of over 16% during the forecast period owing to the increasing prevalence of chronic diseases such as cancer, diabetes, and heart disease.
- Rising demand for regenerative medicine: The growing demand for regenerative medicine is another key factor driving the growth of the stem cell drugs market. Regenerative medicine helps in restoring or repairing tissues and organs that have been damaged by injury or disease.
- Technological advancements: The advent of novel technologies such as 3D printing has led to significant advancements in stem cell therapies, thereby propelling the growth of the stem cell drugs market.
- Growing investments by pharmaceutical companies: Pharmaceutical companies are increasingly investing in research and development activities for novel stem cell therapies, which is likely to boost the growth of this market in future years. For instance, In November 2017, Johnson & Johnson announced an investment totaling USD 240 million over five years for its Janssen Biotech’s Cell Therapy Unit with an aim to develop new treatments using pluripotent cells derived from human embryos (induced pluripotent cells). This will help expand their product offerings in areas such as oncology and immunology disorders . 5) Rising number of clinical trials: Clinical trials are essential steps undertaken before a drug can be approved for use by regulatory authorities across different geographies; they also provide valuable insights into a drug’s
Scope Of The Report
Report Attributes
Report Details
Report Title
Stem Cell Drugs Market Research Report
By Type
Cord Blood-Derived, Adipose-Derived, Bone Marrow-Derived, Others
By Application
Acute Graft-versus-Host Disease, Crohn’s Disease, Amyotrophic Lateral Sclerosis, Osteoarthritis, Others
By Companies
JCR Pharmaceuticals Co., Ltd, CORESTEM, Inc, Pharmicell Co., Ltd, Anterogen, Chiesi Pharmaceuticals, Takeda, New York Blood Center, MEDIPOST
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
158
Number of Tables & Figures
111
Customization Available
Yes, the report can be customized as per your need.
Global Stem Cell Drugs Market Report Segments:
The global Stem Cell Drugs market is segmented on the basis of:
Types
Cord Blood-Derived, Adipose-Derived, Bone Marrow-Derived, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Acute Graft-versus-Host Disease, Crohn’s Disease, Amyotrophic Lateral Sclerosis, Osteoarthritis, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- JCR Pharmaceuticals Co., Ltd
- CORESTEM, Inc
- Pharmicell Co., Ltd
- Anterogen
- Chiesi Pharmaceuticals
- Takeda
- New York Blood Center
- MEDIPOST
Highlights of The Stem Cell Drugs Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Cord Blood-Derived
- Adipose-Derived
- Bone Marrow-Derived
- Others
- By Application:
- Acute Graft-versus-Host Disease
- Crohn’s Disease
- Amyotrophic Lateral Sclerosis
- Osteoarthritis
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Stem Cell Drugs Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Stem cell drugs are medications that help to treat diseases by helping to regenerate damaged cells.
Some of the major companies in the stem cell drugs market are JCR Pharmaceuticals Co., Ltd, CORESTEM, Inc, Pharmicell Co., Ltd, Anterogen, Chiesi Pharmaceuticals, Takeda, New York Blood Center, MEDIPOST.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Stem Cell Drugs Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Stem Cell Drugs Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Stem Cell Drugs Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Stem Cell Drugs Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Stem Cell Drugs Market Size & Forecast, 2020-2028
4.5.1 Stem Cell Drugs Market Size and Y-o-Y Growth
4.5.2 Stem Cell Drugs Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Cord Blood-Derived
5.2.2 Adipose-Derived
5.2.3 Bone Marrow-Derived
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Acute Graft-versus-Host Disease
6.2.2 Crohn’s Disease
6.2.3 Amyotrophic Lateral Sclerosis
6.2.4 Osteoarthritis
6.2.5 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Stem Cell Drugs Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Stem Cell Drugs Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Cord Blood-Derived
9.6.2 Adipose-Derived
9.6.3 Bone Marrow-Derived
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Acute Graft-versus-Host Disease
9.10.2 Crohn’s Disease
9.10.3 Amyotrophic Lateral Sclerosis
9.10.4 Osteoarthritis
9.10.5 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Cord Blood-Derived
10.6.2 Adipose-Derived
10.6.3 Bone Marrow-Derived
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Acute Graft-versus-Host Disease
10.10.2 Crohn’s Disease
10.10.3 Amyotrophic Lateral Sclerosis
10.10.4 Osteoarthritis
10.10.5 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Cord Blood-Derived
11.6.2 Adipose-Derived
11.6.3 Bone Marrow-Derived
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Acute Graft-versus-Host Disease
11.10.2 Crohn’s Disease
11.10.3 Amyotrophic Lateral Sclerosis
11.10.4 Osteoarthritis
11.10.5 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Cord Blood-Derived
12.6.2 Adipose-Derived
12.6.3 Bone Marrow-Derived
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Acute Graft-versus-Host Disease
12.10.2 Crohn’s Disease
12.10.3 Amyotrophic Lateral Sclerosis
12.10.4 Osteoarthritis
12.10.5 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Cord Blood-Derived
13.6.2 Adipose-Derived
13.6.3 Bone Marrow-Derived
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Acute Graft-versus-Host Disease
13.10.2 Crohn’s Disease
13.10.3 Amyotrophic Lateral Sclerosis
13.10.4 Osteoarthritis
13.10.5 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Stem Cell Drugs Market: Competitive Dashboard
14.2 Global Stem Cell Drugs Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 JCR Pharmaceuticals Co., Ltd
14.3.2 CORESTEM, Inc
14.3.3 Pharmicell Co., Ltd
14.3.4 Anterogen
14.3.5 Chiesi Pharmaceuticals
14.3.6 Takeda
14.3.7 New York Blood Center
14.3.8 MEDIPOST
